From Casetext: Smarter Legal Research

Cephalon, Inc. v. Watson Pharms., Inc.

United States Court of Appeals for the Federal Circuit
Jul 13, 2012
2011-1325 (Fed. Cir. Jul. 13, 2012)

Opinion

2011-1325

07-13-2012

CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellees.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in case no. 08-CV-0330, Judge Sue L. Robinson.

ON MOTION


ORDER

Cephalon, Inc. and CIMA Labs, Inc., move for a 30-day extension of time, until August 6, 2012, to file their reply brief due to settlement negotiations.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted.

FOR THE COURT

_________________

Jan Horbaly

Clerk
cc: William F. Lee, Esq.

James K. Stronski, Esq.
s21


Summaries of

Cephalon, Inc. v. Watson Pharms., Inc.

United States Court of Appeals for the Federal Circuit
Jul 13, 2012
2011-1325 (Fed. Cir. Jul. 13, 2012)
Case details for

Cephalon, Inc. v. Watson Pharms., Inc.

Case Details

Full title:CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants, v. WATSON…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jul 13, 2012

Citations

2011-1325 (Fed. Cir. Jul. 13, 2012)